Interactions of corticotropin-releasing ractor, urocortin and citalopram in a primate model of stress-induced amenorrhea

Neuroendocrinology

Volumn 92, Issue 4, 2010, Pages 224-234

  Weissheimer, Karin V ^a,d   Herod, Skyla M ^a   Cameron, Judy L ^c   Bethea, Cynthia L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Corticotropin releasing factor; Dorsal raphe; Macaques; Selective serotonin reuptake inhibitor; Serotonin; Stress; Urocortin I

Indexed keywords

CITALOPRAM; CORTICOTROPIN RELEASING FACTOR; UROCORTIN;

AMENORRHEA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; MACACA; MENTAL STRESS; METABOLIC STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

AMENORRHEA; ANIMALS; CITALOPRAM; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; DRUG INTERACTIONS; FEMALE; MACACA FASCICULARIS; NEUROENDOCRINE CELLS; PRIMATES; SEROTONIN UPTAKE INHIBITORS; STAINING AND LABELING; STRESS, PSYCHOLOGICAL; UROCORTINS;

EID: 78649903383     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319257     Document Type: Article

References (60)

1. Boivin J, Bunting L, Collins JA, Nygren KG: International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007;22:1506-1512.
2. Reindollar RH, Novak M, Tho SP, Mc-Donough PG: Adult-onset amenorrhea: a study of 262 patients. Am J Obstet Gynecol 1986;155:531-543.
3. Berga SL, Loucks TL: Use of cognitive behavior therapy for functional hypothalamic amenorrhea. Ann NY Acad Sci 2006;1092:114-129.
4. Marcus MD, Loucks TL, Berga SL: Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril 2001;76:310-316.
5. Williams NI, Berga SL, Cameron JL: Synergism between psychosocial and metabolic stressors: impact on reproductive function in cynomolgus monkeys. Am J Physiol Endocrinol Metab 2007;293: E270-E276.
6. Bethea CL, Pau FK, Fox S, Hess DL, Berga SL, Cameron JL: Sensitivity to stress-induced reproductive dysfunction linked to activity of the serotonin system. Fertil Steril 2005;83:148-155.
7. Bethea CL, Streicher JM, Mirkes SJ, Sanchez RL, Reddy AP, Cameron JL: Serotonin-related gene expression in female monkeys with individual sensitivity to stress. Neuroscience 2005;132:151-166.
8. Cameron JL: Reproductive dysfunction in primates, behaviorally induced; in Fink G (ed): Encyclopedia of Stress. New York, Academic Press, 2000, pp 366-372.
9. Lima FB, Centeno ML, Costa ME, Reddy AP, Cameron JL, Bethea CL: Stress-sensitive female macaques have decreased fifth Ewing variant (Fev) and serotonin-related gene expression that is not reversed by citalopram. Neuroscience 2009;164:676-691.
10. Bethea CL, Centeno ML, Cameron JL: Neurobiology of stress-induced reproductive dysfunction in female macaques. Mol Neurobiol 2008;38:199-230.
11. Centeno ML, Sanchez RL, Cameron JL, Bethea CL: Hypothalamic expression of serotonin 1A, 2A and 2C receptors and GAD67 in female cynomolgus monkeys with different sensitivity to stress. Brain Research 2007;1142:1-12.
12. Centeno ML, Sanchez RL, Cameron JL, Bethea CL: Hypothalamic gonadotrophinreleasing hormone expression in female monkeys with different sensitivity to stress. J Neuroendocrinol 2007;19:594-604.
13. Centeno ML, Sanchez RL, Reddy AP, Cameron JL, Bethea CL: Corticotropin-releasing hormone and pro-opiomelanocortin gene expression in female monkeys with differences in sensitivity to stress. Neuroendocrinology 2007;86:277-288.
14. Dobson H, Ghuman S, Prabhakar S, Smith R: A conceptual model of the influence of stress on female reproduction. Reproduction 2003;125:151-163.
15. Wang R, Millam JR: Corticotropin-releasinghormone-immunopositive nerve elements in apposition to chicken gonadotropinreleasing-hormone-I-containing perikarya in Japanese quail (Coturnix coturnix japonica) brain. Cell Tissue Res 1999;297:223-228.
16. Williams CL, Nishihara M, Thalabard JC, Grosser PM, Hotchkiss J, Knobil E: Corticotropinreleasing factor and gonadotropinreleasing hormone pulse generator activity in the rhesus monkey: electrophysiological studies. Neuroendocrinology 1990;52:133-137. (Pubitemid 20258868)
17. Bao AM, Hestiantoro A, van Someren EJ, Swaab DF, Zhou JN: Colocalization of corticotropinreleasing hormone and oestrogen receptor-β in the paraventricular nucleus of the hypothalamus in mood disorders. Brain 2005;128:1301-1313.
18. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF: Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology 1994;60:436-444.
19. Delville Y, Stires C, Ferris CF: Distribution of corticotropin-releasing hormone immunoreactivity in golden hamster brain. Brain Res Bull 1992;29:681-684.
20. Frim DM, Robinson BG, Pasieka KB, Majzoub JA: Differential regulation of corticotropinreleasing hormone mRNA in rat brain. Am J Physiol 1990;258: E686-E692.
21. Keegan CE, Herman JP, Karolyi IJ, O'Shea KS, Camper SA, Seasholtz AF: Differential expression of corticotropin-releasing hormone in developing mouse embryos and adult brain. Endocrinology 1994;134:2547-2555.
22. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, et al: Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995;378:287-292.
23. Linthorst AC: Interactions between corticotropinreleasing hormone and serotonin: implications for the aetiology and treatment of anxiety disorders. Handb Exp Pharmacol 2005:181-204.
24. Vasconcelos LA, Donaldson C, Sita LV, Casatti CA, Lotfi CF, Wang L, Cadinouche MZ, Frigo L, Elias CF, Lovejoy DA, Bittencourt JC: Urocortin in the central nervous system of a primate (Cebus apella): sequencing, immunohistochemical, and hybridization histochemical characterization. J Comp Neurol 2003;463:157-175.
25. Kozicz T: Neurons colocalizing urocortin and cocaine-and-amphetamine- regulated transcript immunoreactivities are induced by acute lipopolysaccharide stress in the Edinger-Westphal nucleus in the rat. Neuroscience 2003;116:315-320.
26. Skelton KH, Owens MJ, Nemeroff CB: The neurobiology of urocortin. Regul Pept 2000;93:85-92.
27. Ryabinin AE, Weitemier AZ: The urocortin 1 neurocircuit: ethanol sensitivity and potential involvement in alcohol consumption. Brain Res Rev 2006;52:368-380.
28. Clark MS, McDevitt RA, Hoplight BJ, Neumaier JF: Chronic low dose ovine corticotropin releasing factor or urocortin II into the rostral dorsal raphe alters exploratory behavior and serotonergic gene expression in specific subregions of the dorsal raphe. Neuroscience 2007;146:1888-1905.
29. Hammack SE, Pepin JL, DesMarteau JS, Watkins LR, Maier SF: Low doses of corticotropinreleasing hormone injected into the dorsal raphe nucleus block the behavioral consequences of uncontrollable stress. Behav Brain Res 2003;147:55-64.
30. Hammack SE, Schmid MJ, LoPresti ML, Der-Avakian A, Pellymounter MA, Foster AC, Watkins LR, Maier SF: Corticotropinreleasing hormone type 2 receptors in the dorsal raphe nucleus mediate the behavioral consequences of uncontrollable stress. J Neurosci 2003;23:1019-1025.
31. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ: Selective activation of corticotropinreleasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci 2004;24:1305-1311.
32. Cameron JL, Bytheway JA, Guay S, Bethea CL, Kerr DI, Rockcastle N, Perel JM, Axelson DA: Treatment with a serotonin reuptake inhibitor increases reproductive hormone secretion in stress-sensitive monkeys. Abstracts 34th Annual Meeting of the Society for Neuroscience, San Diego, 2004.
33. Rochat B, Amey M, Baumann P: Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography. Ther Drug Monit 1995;17:273-279.
34. Sit DK, Perel JM, Helsel JC, Wisner KL: Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 2008;69:652-658.
35. Berod A, Hartman BK, Pujol JF: Importance of fixation in immunohistochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase. J Histochem Cytochem 1981;29:844-850.
36. Simmons DM, Arriza JL, Swanson LW: A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J Histotechnol 1989;12:169-181.
37. Palkovits M, Brownstein MJ, Vale W: Distribution of corticotropin- releasing factor in rat brain. Fed Proc 1985;44:215-219.
38. Foote SL, Cha CI: Distribution of corticotropinreleasing-factor-like immunoreactivity in brainstem of two monkey species (Saimiri sciureus and Macaca fascicularis): an immunohistochemical study. J Comp Neurol 1988;276:239-264.
39. May PJ, Reiner AJ, Ryabinin AE: Comparison of the distributions of urocortin-containing and cholinergic neurons in the perioculomotor midbrain of the cat and macaque. J Comp Neurol 2008;507:1300-1316.
40. Giles DE, Berga SL: Cognitive and psychiatric correlates of functional hypothalamic amenorrhea: a controlled comparison. Fertil Steril 1993;60:486-492.
41. Gomez F, Lahmame A, de Kloet ER, Armario A: Hypothalamic-pituitary- adrenal response to chronic stress in five inbred rat strains: differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996;63:327-337.
42. Clark MS, Kaiyala KJ: Role of corticotropinreleasing factor family peptides and receptors in stress-related psychiatric disorders. Semin Clin Neuropsychiatry 2003;8:119-136.
43. Lowry CA, Rodda JE, Lightman SL, Ingram CD: Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 2000;20:7728-7736.
44. Valentino RJ, Lucki I, van Bockstaele E: Corticotropinreleasing factor in the dorsal raphe nucleus: linking stress coping and addiction. Brain Res 2010;1314:29-37.
45. Forster GL, Pringle RB, Mouw NJ, Vuong SM, Watt MJ, Burke AR, Lowry CA, Summers CH, Renner KJ: Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur J Neurosci 2008;28:299-310.
46. Summers CH, Kampshoff JL, Ronan PJ, Lowry CA, Prestbo AA, Korzan WJ, Renner KJ: Monoaminergic activity in subregions of raphe nuclei elicited by prior stress and the neuropeptide corticotropin-releasing factor. J Neuroendocrinol 2003;15:1122-1133.
47. Thomas E, Pernar L, Lucki I, Valentino RJ: Corticotropin-releasing factor in the dorsal raphe nucleus regulates activity of lateral septal neurons. Brain Res 2003;960:201-208.
48. Saphier D, Welch JE, Farrar GE, Nguyen NQ, Aguado F, Thaller TR, Knight DS: Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion. Psychoneuroendocrinology 1994;19:779-797.
49. Phelix CF, Liposits Z, Paull WK: Serotonin-CRF interaction in the bed nucleus of the stria terminalis: a light microscopic doublelabel immunocytochemical analysis. Brain Res Bull 1992;28:943-948.
50. Lowry CA, Hale MW, Plant A, Windle RJ, Shanks N, Wood SA, Ingram CD, Renner KJ, Lightman SL, Summers CH: Fluoxetine inhibits corticotropin-releasing factor (CRF) - induced behavioural responses in rats. Stress 2009;12:225-239.
51. Stout SC, Owens MJ, Nemeroff CB: Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment. J Pharmacol Exp Ther 2002;300:1085-1092.
52. Bethea CL, Centeno ML: Ovarian steroid treatment decreases corticotropin-releasing hormone (CRH) mRNA and protein in the hypothalamic paraventricular nucleus of ovariectomized monkeys. Neuropsychopharmacology 2008;33:546-556.
53. Koob GF: Corticotropin-releasing factor, norepinephrine, and stress. Biol Psychiatry 1999;46:1167-1180.
54. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF: Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996;273:1561-1564.
55. Oki Y, Sasano H: Localization and physiological roles of urocortin. Peptides 2004;25:1745-1749.
56. Pan W, Kastin AJ: Urocortin and the brain. Prog Neurobiol 2008;84:148-156.
57. Bethea CL, Streicher JM, Coleman K, Pau FK, Moessner R, Cameron JL: Anxious behavior and fenfluramine-induced prolactin secretion in young rhesus macaques with different alleles of the serotonin reuptake transporter polymorphism (5HTTLPR). Behav Genet 2004;34:295-307.
58. Lima FB, Henderson JA, Reddy AP, Tokuyama Y, Hubert GW, Kuhar MJ, Bethea CL: Unique responses of midbrain CART neurons in macaques to ovarian steroids. Brain Res 2008;1227:76-88.
59. Skelton KH, Nemeroff CB, Knight DL, Owens MJ: Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci 2000;20:1240-1248.
60. Bethea CL, Lu NZ, Gundlah C, Streicher JM: Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 2002;23:41-100.